Login
From:
PharmaVoice
(Uncensored)
subscribe
7 years after launch, Sanofi’s Dupixent is set for a megablockbuster run | PharmaVoice
https://www.pharmavoice.com/news/sanofi-dupixent-regeneron-blockbuster-sales-earnings-q2/722687/
links
backlinks
Roast topics
Find topics
Find it!
Dupixent hasn’t generated as much buzz as top-sellers like Keytruda or Ozempic, but the drug is boosting Sanofi’s earnings into the future.
